138 related articles for article (PubMed ID: 16331563)
1. [A case-control study on JWA promoter -76G-->C polymorphism and the susceptibility of bladder cancer].
Wu W; Li CP; Chen R; Cao XJ; Li AP; Wang Y; Yang KH; Qian LX; Liu QZ; Li ZL; Zhou JW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):648-52. PubMed ID: 16331563
[TBL] [Abstract][Full Text] [Related]
2. Functional variations in the JWA gene are associated with increased odds of leukemias.
Shen Q; Tang WY; Li CP; Chen R; Zhu YJ; Huang S; Li AP; Zhou JW
Leuk Res; 2007 Jun; 31(6):783-90. PubMed ID: 17049984
[TBL] [Abstract][Full Text] [Related]
3. [Polymorphism of NOS2A promoter -969(G>C) is associated with portal hypertension of liver cirrhosis].
Cheng YQ; Wang WQ; Lin JS; Xiong P; Jiang XD
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):591-5. PubMed ID: 15583989
[TBL] [Abstract][Full Text] [Related]
4. Identification and functional characterization of JWA polymorphisms and their association with risk of gastric cancer and esophageal squamous cell carcinoma in a Chinese population.
Tang WY; Wang L; Li C; Hu ZB; Chen R; Zhu YJ; Shen HB; Wei QY; Zhou JW
J Toxicol Environ Health A; 2007 Jun; 70(11):885-94. PubMed ID: 17479402
[TBL] [Abstract][Full Text] [Related]
5. Functional polymorphisms of JWA gene are associated with risk of bladder cancer.
Li CP; Zhu YJ; Chen R; Wu W; Li AP; Liu J; Liu QZ; Wei QY; Zhang ZD; Zhou JW
J Toxicol Environ Health A; 2007 Jun; 70(11):876-84. PubMed ID: 17479401
[TBL] [Abstract][Full Text] [Related]
6. [Association between single nucleotide polymorphisms in the promoter of cyclooxygenase COX-2 gene and hereditary susceptibility to pancreatic cancer].
Xu DK; Zhang XM; Zhao P; Cai JC; Zhao D; Tan W; Guo YL; Lin DX
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1961-5. PubMed ID: 19062735
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the E-cadherin (CDH1) gene promoter and the risk of bladder cancer.
Kiemeney LA; van Houwelingen KP; Bogaerts M; Witjes JA; Swinkels DW; den Heijer M; Franke B; Schalken JA; Verhaegh GW
Eur J Cancer; 2006 Dec; 42(18):3219-27. PubMed ID: 16934975
[TBL] [Abstract][Full Text] [Related]
8. DNA polymorphisms in exon 1 and promoter of the CDH1 gene and relevant risk of transitional cell carcinoma of the urinary bladder.
Ma X; Xu H; Zheng T; Li HZ; Shi TP; Wang BJ; Ju ZH; Wang C; Zhang GX; Zhang X
BJU Int; 2008 Aug; 102(5):633-6. PubMed ID: 18384629
[TBL] [Abstract][Full Text] [Related]
9. [The relationship between single nucleotide polymorphisms of JWA gene and susceptibility to hypertension in workers exposed to heat stress].
Li RF; Sun JY; Zhang P; Zheng JP
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2011 Dec; 29(12):913-6. PubMed ID: 22357531
[TBL] [Abstract][Full Text] [Related]
10. Association of interleukin-1Ra gene polymorphism in patients with bladder cancer: case control study from North India.
Bid HK; Manchanda PK; Mittal RD
Urology; 2006 May; 67(5):1099-104. PubMed ID: 16698387
[TBL] [Abstract][Full Text] [Related]
11. A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility.
Tasci AI; Tugcu V; Ozbek E; Ozbay B; Simsek A; Koksal V
BJU Int; 2008 Feb; 101(4):503-7. PubMed ID: 17986285
[TBL] [Abstract][Full Text] [Related]
12. [Association analysis of variants in the core promoter region of angiotensinogen gene with essential hypertension in Tibetan population].
Yang C; Qiu C; Lu S; Cen W; Zhuo M; Cui C; Cai D; Zhu X; Liu Y; Zhou W; Zhuang L; Ren D
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Jun; 17(3):149-52. PubMed ID: 10837512
[TBL] [Abstract][Full Text] [Related]
13. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Chen W; Chang GC; Chou MC; Lin LY
Lung Cancer; 2006 Apr; 52(1):15-20. PubMed ID: 16476505
[TBL] [Abstract][Full Text] [Related]
14. Promoter activity of human tissue inhibitor of metalloproteinase 2 gene with novel single nucleotide polymorphisms.
Hegab AE; Sakamoto T; Uchida Y; Nomura A; Ishii Y; Morishima Y; Mochizuki M; Kimura T; Saitoh W; Iizuka T; Kiwamoto T; Sekizawa K
Respirology; 2005 Jan; 10(1):27-30. PubMed ID: 15691234
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations.
El-Shabrawi Y; Wegscheider BJ; Weger M; Renner W; Posch U; Ulrich S; Ardjomand N; Hermann J
Ophthalmology; 2006 Apr; 113(4):695-700. PubMed ID: 16581430
[TBL] [Abstract][Full Text] [Related]
16. A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer.
Hao B; Miao X; Li Y; Zhang X; Sun T; Liang G; Zhao Y; Zhou Y; Wang H; Chen X; Zhang L; Tan W; Wei Q; Lin D; He F
Oncogene; 2006 Jun; 25(25):3613-20. PubMed ID: 16652158
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants in the death receptor 4 gene contribute to susceptibility to bladder cancer.
Wang M; Wang M; Cheng G; Zhang Z; Fu G; Zhang Z
Mutat Res; 2009 Feb; 661(1-2):85-92. PubMed ID: 19070628
[TBL] [Abstract][Full Text] [Related]
18. [Association between genetic polymorphism of UGT1A7 and susceptibility of bladder cancer].
Liu J; Yang XM; Liu G; Chang LS; Zhang LR; Song DK
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3122-5. PubMed ID: 20193274
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer.
Kang S; Kim YB; Kim MH; Yoon KS; Kim JW; Park NH; Song YS; Kang D; Yoo KY; Kang SB; Lee HP
Cancer Lett; 2005 Jan; 217(1):11-6. PubMed ID: 15596291
[TBL] [Abstract][Full Text] [Related]
20. Association between CDH1 haplotypes and gastric cancer risk in a Japanese population.
Yamada H; Shinmura K; Ikeda S; Tao H; Otani T; Hanaoka T; Tsuneyoshi T; Tsugane S; Sugimura H
Scand J Gastroenterol; 2007 Dec; 42(12):1479-85. PubMed ID: 17852867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
